Literature DB >> 17316521

Iron supplementation for postoperative anaemia following major paediatric orthopaedic surgery.

Kelvin K W Lau1, Murali M Utukuri, Manoj Ramachandran, David H A Jones.   

Abstract

INTRODUCTION: There is increasing evidence that the anaemia of surgery is not iron deficient and is, therefore, unresponsive to iron supplementation. Oral iron is best avoided postoperatively, particularly in children, due to its dose-dependent side effects. We undertook a national survey of major paediatric orthopaedic surgical units in the UK to investigate the current management of postoperative anaemia with particular reference to iron supplementation.
MATERIALS AND METHODS: Middle-grade doctors and charge nurses at 23 major paediatric orthopaedic units in the UK were contacted by telephone and a structured questionnaire was used to determine the management of postoperative anaemia in major hip, pelvic and spinal surgery.
RESULTS: Only one (4.3%) of the units surveyed had a formally established protocol for the management of postoperative anaemia. Only 10 out of 23 units (43.5%) did not routinely prescribe iron postoperatively. Of the remaining units, 11 commenced iron based on the postoperative haemoglobin level while only 2 used iron supplementation after investigation of serum haematinics for iron deficiency. One unit used erythropoietin in the treatment of postoperative anaemia.
CONCLUSIONS: Iron supplementation continues to be used in major paediatric orthopaedic surgery in the treatment of postoperative anaemia in the absence of iron deficiency. Given the current available evidence, we call for an end to the practice of routine iron supplementation for postoperative anaemia following major paediatric orthopaedic surgery in the UK.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316521      PMCID: PMC1963521          DOI: 10.1308/003588407X160837

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  15 in total

1.  Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin.

Authors:  R G Rohling; A P Zimmermann; C Breymann
Journal:  J Hematother Stem Cell Res       Date:  2000-08

Review 2.  Bloodless medicine: clinical care without allogeneic blood transfusion.

Authors:  Lawrence T Goodnough; Aryeh Shander; Richard Spence
Journal:  Transfusion       Date:  2003-05       Impact factor: 3.157

3.  Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo.

Authors:  P M Sutton; T Cresswell; J P Livesey; K Speed; T Bagga
Journal:  J Bone Joint Surg Br       Date:  2004-01

4.  Iron supplementation after femoral head replacement for patients with normal iron stores.

Authors:  N P Zauber; A G Zauber; F J Gordon; A C Tillis; H C Leeds; E Berman; A B Kudryk
Journal:  JAMA       Date:  1992 Jan 22-29       Impact factor: 56.272

Review 5.  Erythropoietin therapy.

Authors:  L T Goodnough; T G Monk; G L Andriole
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

6.  Low-dose oral iron absorption test in anaemic patients with and without iron deficiency determined by bone marrow iron content.

Authors:  N M Jensen; M Brandsborg; A M Boesen; H Yde; J F Dahlerup
Journal:  Eur J Haematol       Date:  1999-08       Impact factor: 2.997

7.  Response of the erythron and erythropoietin to autologous blood donations in paediatric subjects. Is erythropoietin supplement necessary?

Authors:  P Han; D Stacy
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

8.  2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis.

Authors:  Cindy N Roy; David A Weinstein; Nancy C Andrews
Journal:  Pediatr Res       Date:  2003-03       Impact factor: 3.756

9.  Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis.

Authors:  C Salvarani; R Baricchi; D Lasagni; L Boiardi; R Piccinini; C Brunati; P Macchioni; I Portioli
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

10.  The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial.

Authors:  T H Price; L T Goodnough; W R Vogler; R A Sacher; R M Hellman; M F Johnston; D C Bolgiano; R I Abels
Journal:  Transfusion       Date:  1996-01       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.